AbbVie Inc.ABBV

Close of Friday, October 23, 2026 · AbbVie Inc. is trading above its Pivot, OnlyAlpha's long-term trend line.

Price

$285.66

vs its Pivot

+21.3%

OnlyAlpha Score

Trend

Above its Pivot

Last 12 months. Solid line: price. Dashed green: the Pivot. ▲ closed at least 1% above the Pivot (in) · ▼ closed below it (out). Hover or drag across the chart for any day.

Returns

1 month	Year to date	1 year	3 years / yr	5 years / yr
+8.4%	+28.8%	+28.6%	+28.3%	+25.6%

Dividend: $6.92 a share over the last 12 months, a 2.42% yield at today's price. A Dividend Aristocrat.

Who runs and owns it

In these funds

IYH · 7.36%HDV · 6.65%DGRO · 2.89%OEF · 0.94%IVV · 0.69%IYY · 0.65%

Big investors that own it (latest 13F)

Norway (Norges Bank) Norway's sovereign wealth fund	0.6% of holdings
New York State Common New York State pension	0.6% of holdings
CalPERS California public pension	0.5% of holdings
Citadel Ken Griffin	0.5% of holdings
Canada Pension Plan CPP Investments	0.5% of holdings

Members of Congress who traded it

Ro Khanna D · CA	17 buys · 17 sells · last buy 2026-06-02
Josh Gottheimer D · NJ	6 buys · 3 sells · last sell 2026-05-05
Lisa McClain R · MI	3 buys · 3 sells · last sell 2025-10-31
Marjorie Taylor Greene R · GA	5 buys · 0 sells · last buy 2025-08-04
John Hoeven R · ND	3 buys · 2 sells · last sell 2017-01-20
Tommy Tuberville R · AL	2 buys · 2 sells · last buy 2024-04-03
Debbie Dingell D · MI	3 buys · 1 sells · last sell 2021-06-18
Jerry Moran R · KS	2 buys · 2 sells · last sell 2020-08-21

Suppliers, customers and partners

Sells to ABBV

Royalty Pharma	Imbruvica, $170M (with J&J)
Halozyme	ENHANZE license

ABBV sells to

McKesson	substantially all US sales combined; none >43%
Cardinal Health	substantially all US sales combined; none >43%
Cencora	substantially all US sales combined; none >43%

Partners and deals

Genmab

EPKINLY co-commercialization

From the companies' own annual reports filed with the SEC.

Healthcare · Pharma

PRGO +28%AMGN +18%AZN -5%BMY +3%GALDY +14%GILD +12%GSK -3%JNJ +7%LLY +17%MRK +15%NVO -13%NVS -0%

Get ABBV in your free daily emailAfter every close: whether ABBV is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track ABBV free → Full Stock check